
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 27 September 2019
Sec. Pharmacology of Anti-Cancer Drugs
Volume 9 - 2019 | https://doi.org/10.3389/fonc.2019.00990
This article is part of the Research Topic Design and Application of Innovative Local Treatments in Glioblastoma and Other Cancers View all 12 articles
This article is a correction to:
RETRACTED: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway
A Corrigendum on
Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway
by Cao, H., Li, W., Zhou, Y., Tan, R., Yang, Y., Zhou, Y., et al. (2019). Front. Oncol. 9:188. doi: 10.3389/fonc.2019.00188
In the original article, there was a mistake in Figure 3H as published. Due to carelessness, the picture of the “k562-indo group” was accidentally placed in the “ku812-indo group”. The corrected Figure 3H appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: bone marrow environment, CXCL12/CXCR4, oroxylin A, Imatinib (IM), β-catenin/P-gp
Citation: Cao H, Li W, Zhou Y, Tan R, Yang Y, Zhou Y, Guo Q and Zhao L (2019) Corrigendum: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway. Front. Oncol. 9:990. doi: 10.3389/fonc.2019.00990
Received: 09 September 2019; Accepted: 16 September 2019;
Published: 27 September 2019.
Edited and reviewed by: Carmen Alvarez-Lorenzo, University of Santiago de Compostela, Spain
Copyright © 2019 Cao, Li, Zhou, Tan, Yang, Zhou, Guo and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qinglong Guo, YW50aWNhbmNlcl9kcnVnQDE2My5jb20=; Li Zhao, emhhb2xpQGNwdS5lZHUuY24=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.